Biktarvy 50-200-25 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB25FAAXR
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $35,662
Award facts
- Contract value 100% obligated
- $35,661.76 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
This delivery order, awarded to AmerisourceBergen Drug Corp on August 21, 2025, provides Biktarvy 50-200-25 mg tablets (30-count units) to the Defense Logistics Agency with a ceiling value of $35,661.76 under firm fixed-price terms. The award represents a competitively awarded, non-set-aside contract with a place of performance in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 billion vehicle running through December 2026 that serves as a comprehensive global pharmaceutical support mechanism for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, has established itself as a critical vendor for federal medical procurement, particularly through its extensive portfolio of deliveries to the Defense Logistics Agency's Medical Supply Chain. The company's federal contracting demonstrates consistent capability in fulfilling diverse pharmaceutical needs across multiple therapeutic domains, from specialty medications to vaccines and medical supplies. The Biktarvy delivery supports the Defense Health Agency and broader military healthcare requirements, leveraging AmerisourceBergen's established infrastructure to supply antiretroviral medications and other essential pharmaceuticals to federal healthcare systems.
Quick answers
Who was awarded contract SPE2DB25FAAXR?
SPE2DB25FAAXR was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 21, 2025.
How much is contract SPE2DB25FAAXR worth?
The government has obligated $35,662 on SPE2DB25FAAXR.
Is contract SPE2DB25FAAXR an order under another contract?
Yes. SPE2DB25FAAXR is a delivery order under SPE2DB24D2010, an indefinite delivery contract.
Was contract SPE2DB25FAAXR competed?
The extent of competition for SPE2DB25FAAXR was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award